Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,487 | -4,069 | -48,955 | -38,929 | -33,478 |
| Depreciation Amortization | 54 | 11 | 377 | 273 | 246 |
| Accounts payable and accrued liabilities | -369 | 976 | 1,260 | 304 | 586 |
| Other Working Capital | -3,831 | 1,251 | 6,078 | 2,519 | 1,870 |
| Other Operating Activity | 32,210 | -940 | 6,771 | 4,700 | 1,237 |
| Operating Cash Flow | $-18,423 | $-2,771 | $-34,469 | $-31,133 | $-29,539 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -2,222 | -27,072 | 25,092 |
| PPE Investments | N/A | -162 | -1,968 | -635 | -525 |
| Net Acquisitions | 3,582 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $3,582 | $-162 | $-4,190 | $-27,707 | $24,567 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 26,325 | 7,338 | 3,514 |
| Debt Repayment | N/A | N/A | -3,000 | -7,200 | -600 |
| Common Stock Issued | 66,956 | N/A | 28,861 | 89,125 | 10 |
| Other Financing Activity | -289 | 4,856 | -8,647 | 0 | -592 |
| Financing Cash Flow | $66,667 | $4,856 | $43,539 | $89,263 | $2,332 |
| Beginning Cash Position | 6,939 | 5,016 | 35,933 | 5,510 | 8,150 |
| End Cash Position | 58,765 | 6,939 | 40,813 | 35,933 | 5,510 |
| Net Cash Flow | $51,826 | $1,923 | $4,880 | $30,423 | $-2,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,423 | -2,771 | -34,469 | -31,133 | -29,539 |
| Capital Expenditure | N/A | -162 | -1,968 | -655 | -525 |
| Free Cash Flow | -18,423 | -2,933 | -36,437 | -31,788 | -30,064 |